title: [Non-small cell lung cancer: Remarkable developments].
authors.affiliation: Hôpital Louis-Pasteur, service d'oncologie et d'hématologie, 6, rue Claude-Bernard, 28630 Chartres-Le-Coudray, France. Electronic address: svignot@ch-chartres.fr.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Vignot
authors.affiliation: Assistance publique-Hôpitaux de Paris, hôpital Tenon, service de pneumologie, 4, rue de la Chine, 75020 Paris, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Wislez
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D016527:Drug Costs; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D058990:Molecular Targeted Therapy; D000077594:Nivolumab; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013450:Sulfones; D000077594:Nivolumab; C586847:ceritinib